David
Jiménez Castro
Profesor/a Titular Universidad
Hospital General Universitario Gregorio Marañón
Madrid, EspañaHospital General Universitario Gregorio Marañón-ko ikertzaileekin lankidetzan egindako argitalpenak (48)
2024
-
Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism
Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246
-
Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine
European Journal of Clinical Investigation
-
Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study
eClinicalMedicine, Vol. 73
-
Statin use and mortality in patients with deep vein thrombosis. Data from the RIETE Registry
Thrombosis Research, Vol. 236, pp. 88-96
-
The prognostic value of blood cellular indices in pulmonary embolism
American Journal of Hematology, Vol. 99, Núm. 9, pp. 1704-1711
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding
Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 7
-
Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study
Thrombosis Research, Vol. 228, pp. 1-9
-
Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations
British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981
2022
-
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
The Lancet Oncology, Vol. 23, Núm. 7, pp. e334-e347
-
Imaging modalities for confirming pulmonary embolism during pregnancy: results from a multicenter international study
European Radiology, Vol. 32, Núm. 2, pp. 1238-1246
-
Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry
Frontiers in Medicine, Vol. 9
-
Rate of Recurrence After Discontinuing Anticoagulation Therapy in Patients With COVID-19-Associated Venous Thromboembolism
JAMA internal medicine, Vol. 182, Núm. 12, pp. 1326-1328
-
Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry
Viruses, Vol. 14, Núm. 2
2021
-
Association between preexisting versus newly identified atrial fibrillation and outcomes of patients with acute pulmonary embolism
Journal of the American Heart Association, Vol. 10, Núm. 17
-
Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis
Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 8, pp. 1981-1989
-
Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study
Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 2, pp. 408-416
-
Presenting Characteristics, Treatment Patterns, and Outcomes among Patients with Venous Thromboembolism during Hospitalization for COVID-19
Seminars in Thrombosis and Hemostasis, Vol. 47, Núm. 4, pp. 351-361
-
Sex-differences in the effect of obstructive sleep apnea on patients hospitalized with pulmonary embolism and on in-hospital mortality
Scientific Reports, Vol. 11, Núm. 1
-
Systematic testing for venous thromboembolism in hospitalized patients with COVID-19 and raised D-dimer levels
Thrombosis Update, Vol. 2